CING

Cingulate Inc. Common Stock

5.71

USD

CING Earnings Reports

Positive Surprise Ratio

CING beat 7 of 16 last estimates.

44%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Cingulate Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, CING reported earnings of -1.35 USD per share (EPS) for Q3 25, missing the estimate of -0.82 USD, resulting in a -63.40% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.37% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were Cingulate Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Cingulate Inc. Common Stock reported EPS of -$1.35, missing estimates by -63.4%, and revenue of $0.00, 0% as expectations.

How did the market react to Cingulate Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -12.37%, changed from $3.80 before the earnings release to $3.33 the day after.

When is Cingulate Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Cingulate Inc. Common Stock's next earnings report?

Based on -- analysts, Cingulate Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.